Table 1.
Comparison of case reports on HIV and MuSK myasthenia gravis.
| Case report | Kurokawa et al. | Kuntzer et al. | Ragunathan et al. |
|---|---|---|---|
| Year reported | 2008 | 2011 | 2015 |
| Age | 58 | 21 | 39 |
| Sex | M | F | F |
| Time from HIV to MG | 5 years | 2 years | 1 year |
| CD4 cell count at diagnosis of MG | ND | 575 | 520 |
| Ptosis | + | + | + |
| Bulbar sign | + | + | – |
| Limb weakness | – | + | – |
| Respiratory failure | – | – | – |
| Repetitive nerve stimulation test | + | + | – |
| Anti-Ach R Ab | – | – | – |
| Thymic hyperplasia | – | ND | ND |
| ART | Efavirenz, Tenofovir, Emtricitabine | Zidovudine, lamivudine, Efavirenz/Tenofovir | Tenofovir/Emtricitabine, Darunavir, Raltegravir |
| MG medication | Pyridostigmine, prednisone, cyclosporine | Pyridostigmine, prednisone, Thymectomy, IVIg, Plasmapheresis, Rituximab | Prednisone, Azathioprine, Plasmapheresis |
M – male; F – female; ND – not mentioned or not done; ‘+’ – positive; ‘–’ – negative; Anti-AchR-Ab – anti-acetylcholine receptor antibody; ART – antiretroviral therapy; IVIg – intravenous immunoglobulin.